Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Belgium / NCT05713448
Recruiting Observational

Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes

NCT05713448 · tracked via the Priya Life Science Belgium tracker
Sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Started
2021-02-24
Last updated
2024-07-01

Condition(s) studied

Type 1 DiabetesObesity

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is to phenotype patients with type 1 diabetes and obesity and their response to treatment with regard to their outcomes

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Signed informed consent * Type 1 Diabetes

Primary outcome measure(s)

  • Prevalence of patients with type 1 diabetes and obesity — Up to 100 years
    Prevalence of obesity in type 1 diabetes

Trial sites (1)

FacilityCityRegionStatus
Departement Endocrinology, University Hospitals Leuven Leuven Belgium Recruiting

More Universitaire Ziekenhuizen KU Leuven trials in Belgium

Botulinum Neurotoxin for Children With CP: a Delicate Balance Between Clinical Benefits and Muscular Harm Recruiting
Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level. Recruiting
Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI) Recruiting
The Role of TRP Channels in DPN Recruiting
Revitalization of Traumatized Immature Permanent Teeth Recruiting

Other trials for the same condition

The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions Active, not recruiting
Prevalence of NAFLD in T1DM Patients Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity Active, not recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) Recruiting
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05713448 on ClinicalTrials.gov ↗ ← All trials in Belgium